Alan Prem kumar

Alan Prem kumar

Alan Prem kumar
Adjunct Assistant Professor
University of North Texas, USA

Biography

Dr. Alan Prem Kumar earned his Ph.D. from University of North Texas, USA. From his Ph.D. work, he discovered a novel regulatory protein, PyrR for the pyrimidine biosynthetic pathway in Pseudomonas. Dr. Kumar then pursued Postdoctoral training in Cancer Research at Sidney Kimmel Cancer Centre, California, USA. He was awarded a Postdoctoral Fellowship for his work on the role of nuclear receptors. Dr. Kumar relocated back to Singapore to join Cancer Science Institute of Singapore, National University of Singapore as an independent Principal Investigator to continue on his expertise on nuclear receptor and cancer pharmacology. His current research interest includes the role of nuclear receptors involved in the regulation of target genes and to elucidate mechanism and associated signal pathways. Another area of interest is aimed at developing new derivative drugs with hopefully fewer side effects. Over the years, Dr. Kumar and his laboratory have forged relationships with scientists in cancer research and with cancer advocacy groups in Singapore.

Research Interest

His current research focuses on better understanding the role of this oncogene which offers great potential for the development of more specifically targeted treatment in the battle against cancer and metastatic disease. His research also includes to understand how nuclear receptors regulate gene expression to affect alterations in phenotype and physiology in response to hormones.